In This Issue.

This document is a summary of articles published in the journal Clinical Pharmacology & Therapeutics. The first article discusses the importance of diversity and inclusion in global drug development, with a focus on the role of clinical pharmacology. It highlights the FDA's draft guidance on diversity plans and provides recommendations for integrating demographics into clinical trials. The second article shares insights and lessons from implementing pharmacogenomics into routine medical care, including education and returning test results to patients. The third article celebrates the centennial of the hormone glucagon and explores its clinical pharmacology. The fourth article discusses safe dosing of carbamazepine for evaluating drug-drug interactions. The final article presents studies on vadadustat exposure and response in patients with chronic kidney disease.

PATIENTS; CLINICAL pharmacology; ACADEMIC medical centers; CHILD patients; MEDICAL care; PHARMACOGENOMICS

Clinical Pharmacology & Therapeutics, 2024, Vol 116, Issue 4, p883

0009-9236

Academic Journal

10.1002/cpt.3412